Current management of fecal incontinence: Choosing amongst treatment options to optimize outcomes

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

566

HTML

5603

Tables (1-8)

195

Sum=6364

Publishing Process of This Article

Item

Count

Browse

1048

Download

791

Sum=1839

Dec 28, 2013 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Dec 28, 2013; 19(48): 9216-9230
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9216

Table 8 Outcomes of dextranomer in hyaluronic acid gel for fecal incontinence

Ref.	Year	Patients (n)	> 50% reduction in fecal incontinence episodes (percentage of patients)	Significant quality of life improvement
Dodi et al[150]	2010	115	64%	Yes
Graf et al[161]	2011	136	52%	Yes
Schwandner et al[159]	2011	21	56%	Yes
Danielson et al[160]	2012	34	76%	Yes
La Torre et al[156]	2013	83	63%	Yes

Citation: Koughnett JAMV, Wexner SD. Current management of fecal incontinence: Choosing amongst treatment options to optimize outcomes. World J Gastroenterol 2013; 19(48): 9216-9230
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9216.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9216